Arkolith/Insider Trading/ANIK/Form 4

Colleran David

EVP, General Counsel, Corp SecAnika Therapeutics, Inc. (ANIK) · full profile →Form 4 · filed Mar 17, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 15, 2026Option exercise(M)6K——69K
Mar 15, 2026Tax withholding(F)2K$14.20$27K68K
Mar 14, 2026Grant(A)5K—$067K
Mar 14, 2026Option exercise(M)9K——62K
Mar 14, 2026Tax withholding(F)4K$14.20$59K63K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 15, 2026Option exercise(M)6K—$06K
Mar 14, 2026Option exercise(M)9K—$019K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-111511) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML